Plante Moran Financial Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-255
Closed -$30K 1035
2021
Q3
$30K Hold
255
0.01% 471
2021
Q2
$30K Hold
255
0.01% 475
2021
Q1
$28K Hold
255
0.01% 476
2020
Q4
$27K Hold
255
0.01% 459
2020
Q3
$24K Hold
255
0.01% 454
2020
Q2
$23K Hold
255
0.01% 403
2020
Q1
$19K Sell
255
-400
-61% -$32.5K 0.01% 394
2019
Q4
$55K Hold
655
0.02% 311
2019
Q3
$48K Hold
655
0.01% 345
2019
Q2
$51K Hold
655
0.02% 341
2019
Q1
$50K Hold
655
0.02% 330
2018
Q4
$45K Buy
655
+400
+157% +$30.3K 0.02% 309
2018
Q3
$22K Hold
255
0.01% 425
2018
Q2
$19K Buy
+255
New +$18.4K 0.01% 478
2017
Q4
Sell
-386
Closed -$26K 889
2017
Q3
$26K Buy
+386
New +$25.8K 0.02% 427
2014
Q1
Sell
-501
Closed -$24K 648
2013
Q4
$24K Buy
+501
New +$22.9K 0.01% 327

Other funds holding FXH

Plante Moran Financial Advisors's FXH Position: Q4 2021 in Review

Plante Moran Financial Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2021, closing a stake of 255 shares — an estimated $30K sold.

Plante Moran Financial Advisors first reported a position in FXH in Q4 2013 and held it in 16 quarters. The position peaked at $55K in Q4 2019. 239 funds tracked by Wall St. Rank hold FXH as of Q4 2021.

  • Plante Moran Financial Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2021 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 255 First Trust Health Care AlphaDEX Fund shares in Q4 2021, an estimated $30K.
  • Plante Moran Financial Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2013 and held it in 16 quarters.
  • Plante Moran Financial Advisors's First Trust Health Care AlphaDEX Fund position peaked at $55K in Q4 2019.
  • 239 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2021.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.